{
  "url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1991/regulation-5",
  "json_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1991/regulation-5.json",
  "legislation": "uksi/1991/1474",
  "legislation_title": "The Medicines (Products for Human Use — Fees) Regulations 1991",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1991",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Inspections in connection with multiple applications for licences",
  "text": "Where an inspection mentioned in regulation 4(b) is made at a site which has been named as a possible site for manufacture or assembly of a medicinal product by more than one applicant for—\n(a) a product licence and that site is located outside the United Kingdom; or\n(b) a manufacturer’s licence and that site is located in the United Kingdom,\nthe fee in respect of that inspection shall be payable in equal proportions by each applicant in connection with an application for such licence.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [
    {
      "type": "amended",
      "affecting": "uksi/1994/696",
      "affecting_title": "The Medicines (Products for Human Use—Fees) Amendment Regulations 1994"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1991/1474/regulation/5",
    "retrieved_at": "2026-10-29T14:42:17.847283+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}